Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Epidemiology and Community Health 2006;60:911-913; doi:10.1136/jech.2006.048769
Copyright © 2006 by the BMJ Publishing Group Ltd.

EDITORIAL

Clinical trials

European Medicines Agency policies for clinical trials leave women unprotected

Maria Teresa Ruiz Cantero1, Maria Angeles Pardo2

1 Department of Public Health, University of Alicante, Alicante, Spain
2 San Juan University Hospital, Alicante, Spain

Correspondence to:
Correspondence to:
M T R Cantero
Department of Public Health, University of Alicante, Apdo 99, 03080-Alicante, Spain; cantero@ua.es


Relevance of equality of gender in clinical research

The first 150 words of the full text of this article appear below.

Specific strategies to implement guidelines for the study and evaluation of gender differences in the clinical evaluation of drugs have not been developed by the European Medicines Agency (EMEA). This agency accepts "that some of the factors that influence the effect of a medicine in the population may be important when considering potential differences in response between men and women" and "gender-specific influences can also play a significant role in drug effect". But besides these statements, in a document about gender considerations in the conduct of clinical trials, the EMEA argues against the need for separate International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines on women as a special population group, based on their internal review and experience, but without providing the sources.1 The lack of sound fundaments of these convictions is worrisome. This paper analyses the document of EMEA,1 . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Chilet-Rosell, E., Ruiz-Cantero, M. T., Horga, J. F. (2009). Women's health and gender-based clinical trials on etoricoxib: methodological gender bias. J Public Health (Oxf) 31: 434-445 [Abstract] [Full Text]  
  • Ruiz-Cantero, M. T., Vives-Cases, C., Artazcoz, L., Delgado, A., Garcia Calvente, M. d. M., Miqueo, C., Montero, I., Ortiz, R., Ronda, E., Ruiz, I., Valls, C. (2007). A framework to analyse gender bias in epidemiological research. J. Epidemiol. Community Health 61: ii46-ii53 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest infectious diseases and epidemilogy jobs

Infectious diseases and epidemilogy jobs